Abstract:Background Lack of appropriate tools and techniques to study fate and functional integration of newly generated neurons has so far hindered understanding of neurogenesis' relevance under physiological and pathological conditions. Current analyses are either dependent on mitotic labeling, for example BrdU-incorporation or retroviral infection, or on the detection of transient immature neuronal markers. Here, we report a transgenic mouse model (DCX-CreERT2) for time-resolved fate analysis of newly generated neurons. This model is based on the expression of a tamoxifen-inducible Cre recombinase under the control of a doublecortin (DCX) promoter, which is specific for immature neuronal cells in the CNS. Results In the DCX-CreERT2 transgenic mice, expression of CreERT2 was restricted to DCX+ cells. In the CNS of transgenic embryos and adult DCX-CreERT2 mice, tamoxifen administration caused the transient translocation of CreERT2 to the nucleus, allowing for the recombination of loxP-flanked sequences. In our system, tamoxifen administration at E14.5 resulted in reporter gene activation throughout the developing CNS of transgenic embryos. In the adult CNS, neurogenic regions were the primary sites of tamoxifen-induced reporter gene activation. In addition, reporter expression could also be detected outside of neurogenic regions in cells physiologically expressing DCX (e.g. piriform cortex, corpus callosum, hypothalamus). Four weeks after recombination, the vast majority of reporter-expressing cells were found to co-express NeuN, revealing the neuronal fate of DCX+ cells upon maturation. Conclusions This first validation demonstrates that our new DCX-CreERT2 transgenic mouse model constitutes a powerful tool to investigate neurogenesis, migration and their long-term fate of neuronal precursors. Moreover, it allows for a targeted activation or deletion of specific genes in neuronal precursors and will thereby contribute to unravel the molecular mechanisms controlling neurogenesis.

Generation of BAF53b-Cre Transgenic Mice with Pan-Neuronal Cre Activities.

Engineering Mouse Cell Fate Controller by Rational Design

A Bacterial Artificial Chromosome Transgenic Mouse Model for Visualization of Neurite Growth.

A Powerful Transgenic Tool for Fate Mapping and Functional Analysis of Newly Generated Neurons

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

A robust and high-throughput Cre reporting and characterization system for the whole mouse brain

Generation of Frizzled10-Cre transgenic mouse line: a useful tool for the study of dorsal telencephalic development.

A Transgenic Cre Mouse Line for the Study of Cortical and Hippocampal Development

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation

Improving cell-specific recombination using AAV vectors in the murine CNS by capsid and expression cassette optimization

Construction of Afp-cre-lacZ Transgenic Mouse Model

The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis

A Cre Transgenic Line for Studying V2 Neuronal Lineages and Functions in the Spinal Cord.

Generation of Tamoxifen-Inducible Tfap2b-CreERT2 Mice Using CRISPR-Cas9.

A combinatory genetic strategy for targeting neurogliaform neurons in the mouse basolateral amygdala

Cell-specific expression of Cre recombinase in rat noradrenergic neurons via CRISPR-Cas9 system

Neuropilin-2 genomic elements drive cre recombinase expression in primitive blood, vascular and neuronal lineages

Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia

Generation and Characterization of the PKCγ-Cre Mouse Line